SCHEMBL4147013

SCHEMBL4147013

Fc1c(F)c(F)c(-c2cccnc2)c(F)c1F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 10/20 0.61
CYP3A4 P08684 5/20 0.61
ALDH1A1 P00352 2/20 0.61
CYP1A2 P05177 1/20 0.61
KDM4E B2RXH2 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CYP2B6 P20813 4/20 0.48
CYP2E1 P05181 3/20 0.48
CYP2C9 P11712 3/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2D6 P10635 1/20 0.48
DHODH Q02127 2/20 0.47
CYP11B2 P19099 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21578105 0.98 CYP2A6 (0.64) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL21578019 0.90 CYP2A6 (0.54) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL12999315 0.89 CYP2A6 (0.48) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL23629596 0.83 KDM4E (0.51) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL3364766 0.83 CYP19A1 (0.42) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL11965538 0.83 CYP2A6 (0.78) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL2652533 0.80 CYP2A6 (0.58) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL30473120 0.77 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL29419014 0.77 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL120088 0.77 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952207-B2 Copper-catalyzed C—H bond arylation THE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-02-10 US disclosed
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION AOC2, AOC3, DBH CYP2A6 45/4885CYP3A4 234/4885ALDH1A1 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.